CIZ — Cizzle Biotechnology Holdings Balance Sheet
0.000.00%
Last trade - 00:00
- £6.54m
- £6.09m
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | — | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Cash and Short Term Investments | 0.004 | 0.378 | 0.084 | 0.875 | 0.478 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 0.092 | 0.031 | 0.006 | 0.051 | 0.095 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Current Assets | 0.096 | 0.409 | 0.09 | 0.955 | 0.705 |
Net Property, Plant And Equipment | 0 | — | — | — | — |
Net Intangible Assets | |||||
Long Term Investments | |||||
Total Assets | 0.096 | 0.409 | 0.09 | 1.16 | 2.79 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 0.331 | 0.071 | 0.058 | 0.218 | 0.145 |
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Total Liabilities | 0.331 | 0.071 | 0.058 | 0.218 | 0.145 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | -0.235 | 0.338 | 0.032 | 0.937 | 2.64 |
Total Liabilities & Shareholders' Equity | 0.096 | 0.409 | 0.09 | 1.16 | 2.79 |
Total Common Shares Outstanding |